Skip to content

Charles River Laboratories CRL Other Restructuring Costs

Other Restructuring Costs at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$25.36M+64.4%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$15M-84.7%
Edwards Lifesciences logo
Edwards LifesciencesEW
$4.78M-68.7%
Crown Holdings logo
Crown HoldingsCCK
$0-100%
Ball Corporation logo
Ball CorporationBALL
$11M-15.4%
Lattice Semiconductor logo
Lattice SemiconductorLSCC
$603K+150%

Segments

By product

See full
Cost of services provided (excluding amortization of intangible assets)$21.19M+60.9%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OtherRestructuringCosts.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's other restructuring costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's other restructuring costs?
Charles River Laboratories (CRL) reported other restructuring costs of $25.36M in Q1 2026.
How has Charles River Laboratories's other restructuring costs changed year-over-year?
Charles River Laboratories's other restructuring costs increased by 64.4% year-over-year, from $15.43M to $25.36M.
What is the long-term trend for Charles River Laboratories's other restructuring costs?
Over 2 years (2023 to 2025), Charles River Laboratories's other restructuring costs has grown at a 97.9% compound annual growth rate (CAGR), from $18.07M to $70.8M.